bioAffinity Technologies shares are trading lower following the pricing of a registered direct offering and concurrent private placement.
Portfolio Pulse from Benzinga Newsdesk
bioAffinity Technologies shares are trading lower following the pricing of a registered direct offering and concurrent private placement.

August 02, 2024 | 3:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
bioAffinity Technologies shares are trading lower due to the pricing of a registered direct offering and concurrent private placement.
The pricing of a registered direct offering and concurrent private placement typically dilutes existing shares, leading to a decrease in share price. This is likely why BIAF shares are trading lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100